Fair Value Considerations (Tables)

6 Months Ended

Dec. 31, 2022

Fair Value Disclosures [Abstract]

Schedule of fair value on a recurring basis

			Fair Value Measurements at December 31, 2022
	Fair Value at December 31,
	2022		(Level 1)		(Level 2)		(Level 3)
	(In thousands)
Liabilities:
Contingent consideration	$	389	$	—	$	—	$	389
CVR liability		810		—		—		810
Derivative warrant liabilities		4,155		—		—		4,155
Total	$	5,354	$	—	$	—	$	5,354

			Fair Value Measurements at June 30, 2022
	Fair Value at June 30,
	2022		(Level 1)		(Level 2)		(Level 3)
	(In thousands)
Liabilities:
Contingent consideration	$	396	$	—	$	—	$	396
CVR liability		578		—		—		578
Derivative warrant liabilities		1,796		—		—		1,796
Total	$	2,770	$	—	$	—	$	2,770

Schedule of changes in Level 3 inputs

	CVR		Contingent			Derivative		Fixed Payment
	Liability		Consideration			Warrant Liabilities		Arrangement
	(In thousands)
Balance as of June 30, 2022	$	578	$	396	$	1,796	$	13,051
Included in earnings		232		(2)		(3,594)		880
Purchases, issues, sales and settlements:
Issues		—		—		5,953		—
Settlements		—		(5)		—		(2,050)
Balance as of December 31, 2022	$	810	$	389	$	4,155	$	11,881

Schedule of significant assumptions used in valuation

Significant assumptions used in valuing CVRs were as follows:

	December 31,
	2022
Leveraged Beta	0.81
Market risk premium	6.22	%
Risk-free interest rate	5.00	%
Discount	21.25	%
Company specific discount	10.00	%

Significant assumptions used in valuing derivative warrant liabilities at issuance date were as follows:

	August 9,
	2022
Expected volatility	89.89	%
Equivalent term (years)	4.11
Risk-free rate	3.09	%
Dividend yield	0.00	%

Significant assumptions used in valuing derivative warrant liabilities were as follows:

	December 31,
	2022
Expected volatility	96.62	%
Equivalent term (years)	4.09 - 4.69
Risk-free rate	4.02 - 4.11	%
Dividend yield	0.00	%